Benzinga - Wed, 30 Dec 2020 06:03:31 -0400
Benzinga - Tue, 29 Dec 2020 13:02:22 -0400
load more
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Earnings

see more
Q3 2020Est.ActualSurprise
EPS-0.360
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ATNMActinium Pharmaceuticals, Inc. (Delaware) Common Stock1.68%112.9M

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock Company Questions & Answers

Q

How do I buy Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM) stock?

A

You can purchase shares of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (AMEX: ATNM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Actinium Pharmaceuticals, Inc. (Delaware) Common Stock's (ATNM) main competitors?

A

There are no as such competitors for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock.

Q

What is the target price for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock?

A

The latest price target for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (AMEX: ATNM) was reported by H.C. Wainwright on 2020-06-04. The analyst firm set a price target for 3.00 expecting ATNM to fall to within 12 months (a possible -63.90% downside). 1 analyst firms have reported ratings in the last year.

Q

How much is Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM) stock ?

A

The stock price for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (AMEX: ATNM) is $8.31 last updated Fri Jan 15 2021 20:59:36 GMT+0000 (Coordinated Universal Time).

Q

When is the next Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM) dividend?

A

There are no upcoming dividends for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock.

Q

When is Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (AMEX:ATNM) reporting earnings?

A
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock’s Q3 earnings are confirmed after-market from now on October 23, 2020.
Q

When is the upcoming split for ATNM?

A

There is no upcoming split for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock.